SecBot SecBot
SECBOTREPLAY Home › Report › VERA

VERA · Three senior executives at Vera Therapeutics, the Chief Regulatory…

Vera Therapeutics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Three senior executives at Vera Therapeutics, the Chief Regulatory Officer, Chief Operating Officer, and Chief Commercial Officer, collectively sold over $266,000 worth of shares in a coordinated open-market transaction on February 23, 2026. All trades occurred at the same price, indicating a planned selling event, though no material non-public information is indicated by the timing.

  • Three C-suite executives sold shares simultaneously on February 23, 2026.
  • Total value of sales: $266,513.79 across 6,348 shares.
  • All transactions were open-market sales (Form 4 'S' codes) at identical price: $41.9839 per share.
  • Sellers include Chief Commercial Officer, Chief Operating Officer, and Chief Regulatory Officer, all key operational leaders.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access